A carregar...
Novel strategies in immune checkpoint inhibitor drug development: How far are we from the paradigm shift?
The development of immune checkpoint inhibitors (ICI) represents a major milestone in immune‐oncology. Over the years these agents have demonstrated efficacy in an increasing array of malignancies. Despite this success however, significant challenges remain. Novel approaches to both drug development...
Na minha lista:
| Publicado no: | Br J Clin Pharmacol |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
John Wiley and Sons Inc.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7444803/ https://ncbi.nlm.nih.gov/pubmed/32394468 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bcp.14355 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|